HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1363713Generated: October 28, 2026
[2-(3-Cyclohexyl-3-phenethylureido)-thiazol-5-ylsulfanyl]-acetic acid → HCID 178472930, compound
https://huagongshe.com/reaction/1363713
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | [2-(3-Cyclohexyl-3-phenethylureido)-thiazol-5-ylsulfanyl]-acetic acid | HCID 11993791 | — |
| Reactant | 4-methyl-N-(3-methylbutyl)cyclohexan-1-amine | HCID 21355636 | — |
| Reactant | (2-Amino-thiazole-5-sulfonylamino)acetic acid ethyl ester | HCID 86253773 | — |
| Catalyst | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 178472930 | HCID 178472930 | — |
Reaction Steps
An equimolar mixture of 1,1-carbonyldiimidazole, (2-amino-thiazole-5-sulfonylamino)-acetic acid ethyl ester and DMAP (5 mol %) in THF was heated for 5 h at 50-60° C. and then cooled to room temperature. Then (3-methyl-butyl)-(4-methyl-cyclohexyl)-amine (1 equivalent; prepared following the procedure described in the preparation of [2-(3-cyclohexyl-3-phenethyl-ureido)-thiazol-5-ylsulfanyl]-acetic acid) was added and the reaction is stirred overnight at room temperature. The reaction mixture was quenched with water. The organic phase was isolated and the aqueous phase was extracted with CH2Cl2, and the combined organic phases were dried and concentrated in vacuo. The crude product was dissolved in MeCN and purified using HPLC to give {2-[3-(3-methyl-butyl)-3-(trans-4-methyl-cyclohexyl)-ureido]-thiazole-5-sulfonylamino}-acetic acid ethyl ester as crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07884210B2 |
|---|
| Source dataset | uspto-grants-2011_02 |
|---|
| ORD ID | ord-9f7628796a88449698d17f9929bd4a6c |
|---|
| Source note | uspto-grants-2011_02 |
|---|